WithdrawnPhase 2NCT02365415
Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
Studying Peripheral pulmonary stenosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Boston Children's Hospital
- Principal Investigator
- Audrey Marshall, MDBoston Children's Hospital
- Intervention
- Sirolimus(drug)
- Eligibility
- All sexes
- Timeline
- 2015 – 2018
Study locations (1)
- Boston Children's Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02365415 on ClinicalTrials.govOther trials for Peripheral pulmonary stenosis
Additional recruiting or active studies for the same condition.